Acute Pain in the Eye

Chapter
Part of the Ocular Trauma book series (OCTRA)

Abstract

A painful eye is not normal, is commonly associated with various sensations, and the accompanying symptoms may be indicative of an ocular emergency. Among those, accompanying vision problems and/or redness of the eyeball require special attention to prevent blindness. A differential diagnosis should be made at presentation by careful ophthalmic examination. Proper management should be instituted in a timely manner to obtain maximum benefit in a patient presenting with acute pain in the eye. This chapter aims to provide an overview on current approaches in an eye with acute pain and glaucoma, scleritis, uveitis, and corneal problems.

Abstract

Similar to acute vision loss, red eye, and photophobia, acute pain in the eye is one of the typical symptoms of an ocular emergency. Although acute eye pain may result from numerous pathologies, an appropriate history will often help the ophthalmologist disclose the underlying disease.

Keywords

Acute pain Glaucoma Scleritis Uveitis Corneal abnormalities 

References

  1. 1.
    Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76(5):521–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Rosenthal P, Baran I, Jacobs DS. Corneal pain without stain: is it real? Ocul Surf. 2009;7(1):28–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Ruskell GL. Ocular fibres of the maxillary nerve in monkeys. J Anat. 1974;118(Pt 2):195–203.PubMedPubMedCentralGoogle Scholar
  4. 4.
    European Glaucoma Society. Guidelines. 4th ed. 2014:100–127.Google Scholar
  5. 5.
    Kanski JJ, Bowling B. Clinical ophthalmology: a systematic approach. 7th ed. Edinburgh: Elsevier Health Sciences; 2011. p. 311–400.CrossRefGoogle Scholar
  6. 6.
    van der Heijden ME, Shah P, Cowan CS, Yang Z, Wu SM, Frankfort BJ. Effects of chronic and acute intraocular pressure elevation on scotopic and photopic contrast sensitivity in mice. Invest Ophthalmol Vis Sci. 2016;57(7):3077–87.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Wright C, Tawfik MA, Waisbourd M, Katz LJ. Primary angle-closure glaucoma: an update. Acta Ophthalmol. 2016;94(3):217–25.PubMedCrossRefGoogle Scholar
  8. 8.
    Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86(2):238–42. ReviewPubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Day AC, Baio G, Gazzard G, Bunce C, Azuara-Blanco A, Munoz B, Friedman DS, Foster PJ. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br J Ophthalmol. 2012;96(9):1162–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Okabe I, Sugiyama K, Taniguchi T, Tomita G, Kitazawa Y. [On factors related to the width of anterior chamber angle – multivariate analysis of biometrically determined values]. Nippon Ganka Gakkai Zasshi. 1991;95(5):486–94. (in Japanese).Google Scholar
  12. 12.
    Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br Ophthalmol. 2001;85(11):1277–82.CrossRefGoogle Scholar
  13. 13.
    Kavitha S, Zebardast N, Palaniswamy K, Wojciechowski R, Chan ES, Friedman DS, Venkatesh R, Ramulu PY. Family history is a strong risk factor for prevalent angle closure in a South Indian population. Ophthalmology. 2014;121(11):2091–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Yazdani S, Akbarian S, Pakravan M, Afrouzifar M. Prevalence of angle closure in siblings of patients with primary angle-closure glaucoma. J Glaucoma. 2015;24(2):149–53.PubMedCrossRefGoogle Scholar
  15. 15.
    Marchini G, Pagliarusco A, Toscano A, Tosi R, Brunelli C, Bonomi L. Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle-closure glaucoma. Ophthalmology. 1998;105(11):2091–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Relhan N, Jalali S, Pehre N, Rao HL, Manusani U, Bodduluri L. High-hyperopia database, Part I: Clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos. Eye (Lond). 2016;30(1):120–6.CrossRefGoogle Scholar
  17. 17.
    Pavlin CJ, Ritch R, Foster FS. Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol. 1992;113(4):390–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Snow JT. Value of prophylactic peripheral iridectomy on the second eye in angle-closure glaucoma. Trans Ophthalmol Soc U K. 1977;97:189–91.PubMedGoogle Scholar
  19. 19.
    He M, Friedman DS, Ge J, Huang W, Jin C, Cai X, Khaw PT, Foster PJ. Laser peripheral iridotomy in eyes with narrow drainage angles: ultrasound biomicroscopy outcomes. Liwan Eye Stud Ophthalmol. 2007;114(8):1513–9.Google Scholar
  20. 20.
    Ritch R, Tham CC, Lam DS. Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology. 2004;111(1):104–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Lee JR, Choi JY, Kim YD, Choi J. Laser peripheral iridotomy with iridoplasty in primary angle closure suspect: anterior chamber analysis by pentacam. Korean J Ophthalmol. 2011;25(4):252–6.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. 2009;54(2):211–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Lam DS, Chua JK, Tham CC, Lai JS. Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma: a pilot study. Ophthalmology. 2002;109:64–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Hayashi K, Hayashi H, Nakao F, Hayashi F. Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. Ophthalmology. 2000;107:698–703.PubMedCrossRefGoogle Scholar
  25. 25.
    Man X, Chan NC, Baig N, Kwong YY, Leung DY, Li FC, Tham CC. Anatomical effects of clear lens extraction by phacoemulsification versus trabeculectomy on anterior chamber drainage angle in primary angle-closure glaucoma (PACG) patients. Graefes Arch Clin Exp Ophthalmol. 2015;253(5):773–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Azuara-Blanco A, Burr J, Ramsay C, Cooper D, Foster PJ, Friedman DS, Scotland G, Javanbakht M, Cochrane C, Norrie J, EAGLE Study Group. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet. 2016;388(10052):1389–97.PubMedCrossRefGoogle Scholar
  27. 27.
    Aung T, Tow SL, Yap EY, Chan SP, Seah SK. Trabeculectomy for acute primary angle closure. Ophthalmology. 2000;107(7):1298–302.PubMedCrossRefGoogle Scholar
  28. 28.
    Tham CC, Kwong YY, Baig N, Leung DY, Li FC, Lam DS. Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology. 2013;120(1):62–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Wang M, Fang M, Bai YJ, Zhang WZ, Lin MK, Liu BQ, Hao YT, Ling YL, Zhuo YH, Ge J. Comparison of combined phacotrabeculectomy with trabeculectomy only in the treatment of primary angle-closure glaucoma. Chin Med J. 2012;125(8):1429–33.PubMedGoogle Scholar
  30. 30.
    Tham CC, Kwong YY, Leung DY, Lam SW, Li FC, Chiu TY, Chan JC, Lam DS, Lai JS. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications [corrected]. Arch Ophthalmol. 2010;128(3):303–11.PubMedCrossRefGoogle Scholar
  31. 31.
    Canlas OA, Ishikawa H, Liebmann JM, Tello C, Ritch R. Ultrasound biomicroscopy before and after goniosynechialysis. Am J Ophthalmol. 2001;132(4):570–1.PubMedCrossRefGoogle Scholar
  32. 32.
    Deokule SP, Molteno AC, Bevin TH, Herbison P. Long-term results of Molteno implant insertion in cases of chronic angle closure glaucoma. Clin Exp Ophthalmol. 2007;35(6):514–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Lai J, Choy BN, Shum JW. Management of primary angle-closure glaucoma. Asia Pac J Ophthalmol (Phila). 2016;5(1):59–62.CrossRefGoogle Scholar
  34. 34.
    Anwar F, Turalba A. An overview of treatment methods for primary angle closure. Semin Ophthalmol. 2017;32:82–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Cioffi GA, editor. Basic and clinical science course (BCSC), Section 10: Glaucoma. San Francisco: American Academy of Ophthalmology; 2015–2016.Google Scholar
  36. 36.
    Pieramici DJ, Parver LM. A mechanistic approach to ocular trauma. Ophthalmol Clin N Am. 1995;8:569–87.Google Scholar
  37. 37.
    Ng DS, Ching RH, Chan CW. Angle-recession glaucoma: long-term clinical outcomes over a 10-year period in traumatic microhyphema. Int Ophthalmol. 2015;35(1):107–13.PubMedCrossRefGoogle Scholar
  38. 38.
    Kaufman JH, Tolpin DW. Glaucoma after traumatic angle recession. A ten-year prospective study. Am J Ophthalmol. 1974;78(4):648–54.PubMedCrossRefGoogle Scholar
  39. 39.
    Tumbocon JA, Latina MA. Angle recession glaucoma. Int Ophthalmol Clin. 2002;42(3):69–78. ReviewPubMedCrossRefGoogle Scholar
  40. 40.
    Salmon JF, Mermoud A, Ivey A, Swanevelder SA, Hoffman M. The detection of post-traumatic angle recession by gonioscopy in a population-based glaucoma survey. Ophthalmology. 1994;101(11):1844–50.PubMedCrossRefGoogle Scholar
  41. 41.
    Mermoud A, Salmon JF, Barron A, Straker C, Murray AD. Surgical management of post-traumatic angle recession glaucoma. Ophthalmology. 1993;100(5):634–42.PubMedCrossRefGoogle Scholar
  42. 42.
    Acar U, Tok OY, Acar DE, Burcu A, Ornek F. A new ocular trauma score in pediatric penetrating eye injuries. Eye (Lond). 2011;25(3):370–4.CrossRefGoogle Scholar
  43. 43.
    Canavan YM, Archer DB. Anterior segment consequences of blunt ocular injury. Br J Ophthalmol. 1982;66:549–55.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Ekşioğlu Ü. Clinical evaluation of ocular trauma. Turk J Ophthalmol. 2012;42:16–22.Google Scholar
  45. 45.
    Pilger IS, Khwarg SG. Angle recession glaucoma: review and two case reports. Ann Ophthalmol. 1985;17(3):197–9.PubMedGoogle Scholar
  46. 46.
    Mermoud A, Salmon JF, Straker C, Murray AD. Post-traumatic angle recession glaucoma: a risk factor for bleb failure after trabeculectomy. Br J Ophthalmol. 1993;77(10):631–4.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Singh G, Kaur J, Dogra A. Intraoperative mitomycin C in complicated glaucomas. Indian J Ophthalmol. 1993;41(2):78–80.PubMedGoogle Scholar
  48. 48.
    Koçak-Midillioğlu İ, KaralezliI A, Yalvaç L, Ekşioğlu Ü, Duman S. Medical and surgical management of angle recession glaucoma. Turk J Ophthalmol. 2002;32:849–55.Google Scholar
  49. 49.
    Lew M, Lew S, Brzeski W. Short-term results of Ahmed glaucoma valve implantation in the surgical treatment of angle-recession glaucoma in dog. Pol J Vet Sci. 2008;11(4):377–83.PubMedGoogle Scholar
  50. 50.
    Bleiman BS, Schwartz AL. Paradoxical intraocular pressure response to pilocarpine. A proposed mechanism and treatment. Arch Ophthalmol. 1979;97(7):1305–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Liu L, Ong EL, Crowston J. The concave iris in pigment dispersion syndrome. Ophthalmology. 2011;118(1):66–70.PubMedCrossRefGoogle Scholar
  52. 52.
    Potash SD, Tello C, Liebmann J, Ritch R. Ultrasound biomicroscopy in pigment dispersion syndrome. Ophthalmology. 1994;101(2):332–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Gottanka J, Johnson DH, Grehn F, Lütjen-Drecoll E. Histologic findings in pigment dispersion syndrome and pigmentary glaucoma. J Glaucoma. 2006;15(2):142–51.PubMedCrossRefGoogle Scholar
  54. 54.
    Alvarado JA, Murphy CG. Outflow obstruction in pigmentary and primary open angle glaucoma. Arch Ophthalmol. 1992;110:1769–78.PubMedCrossRefGoogle Scholar
  55. 55.
    Yang JW, Sakiyalak D, Krupin T. Pigmentary glaucoma. J Glaucoma. 2001;10(5 Suppl 1):S30–2.PubMedCrossRefGoogle Scholar
  56. 56.
    Andersen JS, Pralea AM, DelBono EA, Haines JL, Gorin MB, Schuman JS, Mattox CG, Wiggs JL. A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol. 1997;115(3):384–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O, Roderick TH, Heckenlively JR, Davisson MT, John SW. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet. 1999;21(4):405–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma – a major review. Clin Exp Ophthalmol. 2008;36(9):868–82.PubMedCrossRefGoogle Scholar
  59. 59.
    Gomez Goyeneche HF, Hernandez-Mendieta DP, Rodriguez DA, Sepulveda AI, Toledo JD. Pigment dispersion syndrome progression to pigmentary glaucoma in a latin american population. J Curr Glaucoma Pract. 2015;9(3):69–72.PubMedCrossRefGoogle Scholar
  60. 60.
    Richter CU, Richardson TM, Grant WM. Pigmentary dispersion syndrome and pigmentary glaucoma: a prospective study of the natural history. Arch Ophthalmol. 1986;104(2):211–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Migliazzo CV, Shaffer RN, Nykin R, Magee S. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1986;93(12):1528–36.PubMedCrossRefGoogle Scholar
  62. 62.
    Siddiqui Y, Ten Hulzen RD, Cameron JD, Hodge DO, Johnson DH. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003;135(6):794–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Haddad R, Strasser G, Heilig P, Jurecka W. Decompensation of chronic open-angle glaucoma following mydriasis-induced pigmentary dispersion into the aqueous humour: a light and electron microscopic study. Br J Ophthalmol. 1981;65:252–7.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Haynes WL, Johnson AT, Alward WLM. Effects of jogging exercise on patients with the pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1992;99:1096–103.PubMedCrossRefGoogle Scholar
  65. 65.
    Schenker HI, Luntz MH, Kels B, Podos SM. Exercise-induced increase of intraocular pressure in the pigmentary dispersion syndrome. Am J Ophthalmol. 1980;89:598–600.PubMedCrossRefGoogle Scholar
  66. 66.
    Jensen PK, Nissen O, Kessing SV. Exercise and reversed pupillary block in pigmentary glaucoma. Am J Ophthalmol. 1995;120:110–2.PubMedCrossRefGoogle Scholar
  67. 67.
    Campbell DG. Iridotomy, blinking and pigmentary glaucoma. Invest Ophthalmol Vis Sci. 1993;34(Suppl):993.Google Scholar
  68. 68.
    Balidis MO, Bunce C, Sandy CJ, Wormald RPL, Miller MH. Iris configuration in accommodation in pigment dispersion syndrome. Eye. 2002;16:694–700.PubMedCrossRefGoogle Scholar
  69. 69.
    Campbell DG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol. 1979;97:1667–72.PubMedCrossRefGoogle Scholar
  70. 70.
    Chang SH, Wu WC, Wu SC. Late-onset secondary pigmentary glaucoma following foldable intraocular lenses implantation in the ciliary sulcus: a long-term follow-up study. BMC Ophthalmol. 2013;13:22.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Grierson I, Jonsson M, Cracknell K. Latanoprost and pigmentation. Jpn J Ophthalmol. 2004;48:602–12.PubMedCrossRefGoogle Scholar
  72. 72.
    Gandolfi SA, Vecchi M. Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome. Ophthalmology. 1996;103(10):1693–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Pavlin CJ, Macken P, Trope GE, Harasiewicz K, Foster FS. Accommodation and iridotomy in the pigment dispersion syndrome. Ophthalmic Surg Lasers. 1996;27(2):113–20.PubMedGoogle Scholar
  74. 74.
    Michelessi M, Lindsley K. Peripheral iridotomy for pigmentary glaucoma. Cochrane Database Syst Rev. 2016;2:CD005655.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Ritch R, Liebmann J, Robin A, Pollack IP, Harrison R, Levene RZ, Hagadus J. Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology. 1993;100(6):909–13.PubMedCrossRefGoogle Scholar
  76. 76.
    Lehto I. Long-term follow up of argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmic Surg. 1992;23(9):614–7.PubMedGoogle Scholar
  77. 77.
    Khouri AS, Lari HB, Berezina TL, Maltzman B, Fechtner RD. Long term efficacy of repeat selective laser trabeculoplasty. J Ophthalmic Vis Res. 2014;9(4):444–8.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Qing GP, Wang NL, Wang T, Chen H, Mou DP. Long-term efficacy of trabeculectomy on Chinese patients with pigmentary glaucoma: a prospective case series observational study. Chin Med J (Engl). 2016;129(11):1268–72.CrossRefGoogle Scholar
  79. 79.
    Suñer IJ, Greenfield DS, Miller MP, Nicolela MT, Palmberg PF. Hypotony maculopathy after filtering surgery with mitomycin C. Incid treat Ophthalmol. 1997;104(2):207–14.Google Scholar
  80. 80.
    Wilson FM. Traumatic hyphema. Pathogenesis and management. Ophthalmology. 1980;87:910–9.Google Scholar
  81. 81.
    Wong TY, Tielsch JM. A population-based study on the incidence of severe ocular trauma in Singapore. Am J Ophthalmol. 1999;128(3):345–51.PubMedCrossRefGoogle Scholar
  82. 82.
    Goetz RK, Cosgrave E. Spontaneous hyphaemas requiring a closer look. BMJ Case Rep. 2016;2016Google Scholar
  83. 83.
    Dharmasena A, Watts GM. Bilateral spontaneous hyphaema: case report and review of literature. J Thromb Thrombolysis. 2013;36(3):343–5.PubMedCrossRefGoogle Scholar
  84. 84.
    Shimada Y, Horiguchi M, Okubo T. Bilateral spontaneous hyphema with uveitis in a young girl. J Pediatr Ophthalmol Strabismus. 2004;41(2):114–5.PubMedGoogle Scholar
  85. 85.
    Valent DJ Jr, Augsburger JJ, Corrêa ZM. Embyronal carcinoma of testis metastatic to ciliary body presenting as spontaneous hyphema and painful secondary glaucoma. Retin Case Brief Rep. 2013;7(1):105–7.CrossRefGoogle Scholar
  86. 86.
    Aljalbout Y, Sandadi J. Spontaneous hyphema in a patient undergoing laparoscopic appendectomy. A A Case Rep. 2013;1(1):8.PubMedCrossRefGoogle Scholar
  87. 87.
    Trivedi D, Newton JD, Mitra A, Puri P. A serious drug interaction leading to spontaneous total hyphema. J Postgrad Med. 2010;56(1):46–7.PubMedCrossRefGoogle Scholar
  88. 88.
    Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K. Medical interventions for traumatic hyphema. Cochrane Database Syst Rev. 2013;12:CD005431.PubMedCentralGoogle Scholar
  89. 89.
    Kearns P. Traumatic hyphaema: a retrospective study of 314 cases. Br J Ophthalmol. 1991;75(3):137–41.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Lawrence T, Wilison D, Harvey J. The incidence of secondary hemorrhage after traumatic hyphema. Ann Ophthalmol. 1990;22(7):276–8.PubMedGoogle Scholar
  91. 91.
    Türkcü FM, Yüksel H, Sahin A, Cingü K, Arı S, Cınar Y, Sahin M, Yıldırım A, Caça I. Demographic and etiologic characteristics of children with traumatic serious hyphema. Ulus Travma Acil Cerrahi Derg. 2013;19(4):357–62.PubMedCrossRefGoogle Scholar
  92. 92.
    Agapitos PJ, Noel LP, Clarke WN. Traumatic hyphema in children. Ophthalmology. 1987;94(10):1238–41.PubMedCrossRefGoogle Scholar
  93. 93.
    Kennedy RH, Brubaker RF. Traumatic hyphema in a defined population. Am J Ophthalmol. 1988;106(2):123–30.PubMedCrossRefGoogle Scholar
  94. 94.
    Rakusin W. Traumatic hyphema. Am J Ophthalmol. 1972;74:284–92.PubMedCrossRefGoogle Scholar
  95. 95.
    Hallet C, Willoughby C, Shafiq A, Kaye SB, Bolton-Maggs PH. Pitfalls in the management of a child with mild haemophilia A and a traumatic hyphaema. Haemophilia. 2000;6(2):118–9.PubMedCrossRefGoogle Scholar
  96. 96.
    Rahmani B, Jahadi HR, Rajaeefard A. An analysis of risk for secondary hemorrhage in traumatic hyphema. Ophthalmology. 1999;106(2):380–5.PubMedCrossRefGoogle Scholar
  97. 97.
    Walton W, Von Hagen S, Grigorian R, Zarbin M. Management of traumatic hyphema. Surv Ophthalmol. 2002;47(4):297–334.PubMedCrossRefGoogle Scholar
  98. 98.
    Bansal S, Gunasekeran DV, Ang B, Lee J, Khandelwal R, Sullivan P, Agrawal R. Controversies in the pathophysiology and management of hyphema. Surv Ophthalmol. 2016;61(3):297–308.PubMedCrossRefGoogle Scholar
  99. 99.
    Brodrick JD. Corneal blood staining after hyphaema. Br J Ophthalmol. 1972;56(8):589–93.PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Gottsch JD, Messmer EP, McNair DS, Font RL. Corneal blood staining: an animal model. Ophthalmology. 1986;93:797.PubMedCrossRefGoogle Scholar
  101. 101.
    Crawford JS, Lewandowski RL, Chan W. The effect of aspirin on rebleeding in traumatic hyphema. Am J Ophthalmol. 1975;80(3 Pt 2):543–5.PubMedCrossRefGoogle Scholar
  102. 102.
    Pieramici DJ, Goldberg MF, Melia M, Fekrat S, Bradford CA, Faulkner A, Juzych M, Parker JS, McLeod SD, Rosen R, Santander SH. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. Ophthalmology. 2003;110(11):2106–12.PubMedCrossRefGoogle Scholar
  103. 103.
    Jahadi Hosseini SH, Khalili MR, Motallebi M. Comparison between topical and oral tranexamic acid in management of traumatic hyphema. Iran J Med Sci. 2014;39(2 Suppl):178–83.PubMedPubMedCentralGoogle Scholar
  104. 104.
    Rahmani B, Jahadi HR. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. Ophthalmology. 1999;106(2):375–9.PubMedCrossRefGoogle Scholar
  105. 105.
    Albiani DA, Hodge WG, Pan YI, Urton TE, Clarke WN. Tranexamic acid in the treatment of pediatric traumatic hyphema. Can J Ophthalmol. 2008;43(4):428–31.PubMedCrossRefGoogle Scholar
  106. 106.
    Ng CS, Strong NP, Sparrow JM, Rosenthal AR. Factors related to the incidence of secondary haemorrhage in 462 patients with traumatic hyphema. Eye. 1992;6(Pt 3):308–12.PubMedCrossRefGoogle Scholar
  107. 107.
    Romano PE, Phillips PJ. Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol. Binocul Vis Strabismus Q. 2000;15(2):187–96.PubMedGoogle Scholar
  108. 108.
    Romano PE, Robinson JA. Traumatic hyphema: a comprehensive review of the past half century yields 8076 cases for which specific medical treatment reduces rebleeding 62%, from 13% to 5% (P<.0001). Binocul Vis Strabismus Q. 2000;15(2):175–86.PubMedGoogle Scholar
  109. 109.
    Farber MD, Fiscella R, Goldberg MF. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial. Ophthalmology. 1991;98(3):279–86.PubMedCrossRefGoogle Scholar
  110. 110.
    Read J. Traumatic hyphema: surgical vs medical management. Ann Ophthalmol. 1975;7(5):659–62. 664-6, 668-70PubMedGoogle Scholar
  111. 111.
    Graul TA, Ruttum MS, Lloyd MA, Radius RL, Hyndiuk RA. Trabeculectomy for traumatic hyphema with increased intraocular pressure. Am J Ophthalmol. 1994;117(2):155–9.PubMedCrossRefGoogle Scholar
  112. 112.
    Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60(3):163–91.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102(4):687–92.PubMedCrossRefGoogle Scholar
  114. 114.
    Rachitskaya A, Mandelcorn ED, Albini TA. An update on the cause and treatment of scleritis. Curr Opin Ophthalmol. 2010;21(6):463–7.PubMedCrossRefGoogle Scholar
  115. 115.
    Ramenaden ER, Raiji VR. Clinical characteristics and visual outcomes in infectious scleritis: a review. Clin Ophthalmol. 2013;7:2113–22.PubMedPubMedCentralGoogle Scholar
  116. 116.
    Lin P, Bhullar SS, Tessler HH, Goldstein DA. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol. 2008;145(3):463–71.PubMedCrossRefGoogle Scholar
  117. 117.
    Jain V, Garg P, Sharma S. Microbial scleritis-experience from a developing country. Eye (Lond). 2009;23(2):255–61.CrossRefGoogle Scholar
  118. 118.
    Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101(2):389–96.PubMedCrossRefGoogle Scholar
  119. 119.
    Weisenthal RW, editor. Basic and clinical science course (BCSC), Section 8: External disease and cornea. San Francisco: American Academy of Ophthalmology; 2015–2016.Google Scholar
  120. 120.
    Su CY, Tsai JJ, Chang YC, Lin CP. Immunologic and clinical manifestations of infectious scleritis after pterygium excision. Cornea. 2006;25(6):663–6.PubMedCrossRefGoogle Scholar
  121. 121.
    Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013;32(12):1562–6.PubMedCrossRefGoogle Scholar
  122. 122.
    Daniel Diaz J, Sobol EK, Gritz DC. Treatment and management of scleral disorders. Surv Ophthalmol. 2016;61(6):702–17.PubMedCrossRefGoogle Scholar
  123. 123.
    Sims J. Scleritis: presentations, disease associations and management. Postgrad Med J. 2012;88(1046):713–8.PubMedCrossRefGoogle Scholar
  124. 124.
    Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol. 2002;120(1):15–9.PubMedCrossRefGoogle Scholar
  125. 125.
    Usui Y, Parikh J, Goto H, Rao NA. Immunopathology of necrotising scleritis. Br J Ophthalmol. 2008;92(3):417–9.PubMedCrossRefGoogle Scholar
  126. 126.
    Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza M, Foster CS. Clinical features and presentation of posterior scleritis: a report of 31 cases. Ocul Immunol Inflamm. 2014;22(3):203–7.PubMedCrossRefGoogle Scholar
  127. 127.
    Hodson KL, Galor A, Karp CL, Davis JL, Albini TA, Perez VL, Miller D, Forster RK. Epidemiology and visual outcomes in patients with infectious scleritis. Cornea. 2013;32(4):466–72.PubMedCrossRefGoogle Scholar
  128. 128.
    Roufas A, Jalaludin B, Gaskin C, McCluskey P. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis. Br J Ophthalmol. 2010;94(6):743–7.PubMedCrossRefGoogle Scholar
  129. 129.
    Albini TA, Zamir E, Read RW, Smith RE, See RF, Rao NA. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology. 2005;112(10):1814–20.PubMedCrossRefGoogle Scholar
  130. 130.
    Oray M, Meese H, Foster CS. Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Rev Clin Immunol. 2016;12(8):827–37.PubMedCrossRefGoogle Scholar
  131. 131.
    de Fidelix TS, Vieira LA, de Freitas D, Trevisani VF. Biologic therapy for refractory scleritis: a new treatment perspective. Int Ophthalmol. 2015;35(6):903–12.PubMedCrossRefGoogle Scholar
  132. 132.
    Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785–96.PubMedCrossRefGoogle Scholar
  133. 133.
    Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Smith JR, Rosenbaum JT. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology. 2014;121(10):1885–91.PubMedCrossRefGoogle Scholar
  134. 134.
    Tittler EH, Nguyen P, Rue KS, Vasconcelos-Santos DV, Song JC, Irvine JA, Smith RE, Rao NA, Yiu SC. Early surgical debridement in the management of infectious scleritis after pterygium excision. J Ophthalmic Inflamm Infect. 2012;2(2):81–7.PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–16.PubMedCrossRefGoogle Scholar
  136. 136.
    Read RW, editor. Basic and clinical science course (BCSC), Section 9: Intraocular inflammation and uveitis. San Francisco: American Academy of Ophthalmology; 2015–2016.Google Scholar
  137. 137.
    Islam N, Pavesio C. Uveitis (acute anterior). BMJ Clin Evid. 2010;2010.Google Scholar
  138. 138.
    Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, Androudi S. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2017;49:1–15.Google Scholar
  139. 139.
    Sabhapandit S, Murthy SI, Singh VM, Gaitonde K, Gopal M, Marsonia K, Sajid S, Babu K. Epidemiology and clinical features of uveitis from urban populations in South India. Ocul Immunol Inflamm. 2017;25:S39–45.PubMedCrossRefGoogle Scholar
  140. 140.
    Thorne JE, Suhler E, Skup M, Tari S, Macaulay D, Chao J, Ganguli A. Prevalence of noninfectious uveitis in the United States: a claims-based analysis. JAMA Ophthalmol. 2016;134(11):1237–45.PubMedCrossRefGoogle Scholar
  141. 141.
    Jones NP. The Manchester Uveitis Clinic: the first 3000 patients – epidemiology and casemix. Ocul Immunol Inflamm. 2015;23(2):118–26.PubMedCrossRefGoogle Scholar
  142. 142.
    Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiology of uveitis in Switzerland. Ocul Immunol Inflamm. 1994;2(3):169–76.PubMedCrossRefGoogle Scholar
  143. 143.
    Chang JH, Raju R, Henderson TR, McCluskey PJ. Incidence and pattern of acute anterior uveitis in Central Australia. Br J Ophthalmol. 2010;94(2):154–6.PubMedCrossRefGoogle Scholar
  144. 144.
    Päivönsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, Saari KM. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand. 1997;75(1):76–81.PubMedCrossRefGoogle Scholar
  145. 145.
    Jabbarvand M, Hashemian H, Khodaparast M, Jouhari M, Tabatabaei A, Rezaei S. Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors. Ophthalmology. 2016;123(2):295–301.PubMedCrossRefGoogle Scholar
  146. 146.
    Lundström M, Friling E, Montan P. Risk factors for endophthalmitis after cataract surgery: predictors for causative organisms and visual outcomes. J Cataract Refract Surg. 2015;41(11):2410–6.PubMedCrossRefGoogle Scholar
  147. 147.
    Schwartz SG, Flynn HW Jr, Das T, Mieler WF. Ocular infection: endophthalmitis. Dev Ophthalmol. 2016;55:176–88.PubMedCrossRefGoogle Scholar
  148. 148.
    Hashemian H, Mirshahi R, Khodaparast M, Jabbarvand M. Post-cataract surgery endophthalmitis: brief literature review. J Curr Ophthalmol. 2016;28(3):101–5.PubMedPubMedCentralCrossRefGoogle Scholar
  149. 149.
    Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015;9:95–108.PubMedPubMedCentralGoogle Scholar
  150. 150.
    Holland EJ, McDonald MB, Parekh JG, Sheppard JD. Antibiotic resistance in acute postoperative endophthalmitis. Ophthalmology. 2014;121(11 Suppl):S1–9; quiz S10–2.Google Scholar
  151. 151.
    Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479–96.CrossRefGoogle Scholar
  152. 152.
    Balta Ö, Acar U, Akbaş Kocaoğlu F, Örnek F. Review of 306 evisceration surgeries performed between 2005 and 2013. Turk J Med Sci. 2016;46(2):463–7.PubMedCrossRefGoogle Scholar
  153. 153.
    Sridhar J, Isom RF, Schiffman JC, Ajuria L, Huang LC, Gologorsky D, Banta JT. Utilization of ophthalmology-specific emergency department services. Semin Ophthalmol; 2017. [Epub ahead of print].Google Scholar
  154. 154.
    Lim CH, Turner A, Lim BX. Patching for corneal abrasion. Cochrane Database Syst Rev. 2016;7:CD004764.PubMedGoogle Scholar
  155. 155.
    Pflipsen M, Massaquoi M, Wolf S. Evaluation of the painful eye. Am Fam Physician. 2016;93(12):991–8.PubMedGoogle Scholar
  156. 156.
    Ahmed F, House RJ, Feldman BH. Corneal abrasions and corneal foreign bodies. Prim Care. 2015;42(3):363–75.PubMedCrossRefGoogle Scholar
  157. 157.
    Wipperman JL, Dorsch JN. Evaluation and management of corneal abrasions. Am Fam Physician. 2013;87(2):114–20.PubMedGoogle Scholar
  158. 158.
    Aslam SA, Sheth HG, Vaughan AJ. Emergency management of corneal injuries. Injury. 2007;38:594–7.PubMedCrossRefGoogle Scholar
  159. 159.
    Lee SY, Kim YH, Johnson D, Mondino BJ, Weissman BA. Contact lens complications in an urgent-care population: the University of California, Los Angeles, contact lens study. Eye Contact Lens. 2012;38(1):49–52.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.World Eye HospitalAnkaraTurkey
  2. 2.Department of Ophthalmology, Faculty of MedicineGazi UniversityAnkaraTurkey
  3. 3.Department of Ophthalmology, Faculty of MedicineHacettepe UniversityAnkaraTurkey

Personalised recommendations